Login / Signup
Jay Jiyong Kwak
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
2025
2016
Top Topics
2025
2016
Copy Number
2025
2016
Sars Cov
2025
2016
Gene Therapy
2025
2016
Late Onset
Top Venues
Yonsei medical journal
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jay Jiyong Kwak
,
Hae Rang Kim
,
Suk Ho Byeon
Short-Term Outcomes of the First in Vivo Gene Therapy for RPE65-Mediated Retinitis Pigmentosa.
Yonsei medical journal
63 (7) (2022)